ARA290 16mg
For In Vitro Use Only — Not for Human Use
Every batch is independently HPLC & mass-spec tested. Certificate of Analysis is batch-numbered and matched to the vial you receive.
Erythropoietin-derived peptide fragment (Cibinetide), lyophilised powder (16mg, ≥98% purity) for in vitro research into tissue protection and regenerative signalling pathways.
Overview
ARA290 16mg is a synthetic peptide fragment derived from the erythropoietin receptor-binding domain, supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into tissue-protective signalling, receptor interaction, and regenerative pathway modelling.
Research
Within laboratory settings, ARA290 (Cibinetide) is studied for its interaction with the innate repair receptor and related protective signalling cascades. Research applications commonly focus on tissue protection, nerve-related pathway modelling, and cellular stress responses under controlled experimental conditions.
